{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T20:19:56Z","timestamp":1760645996577},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1097\/cad.0b013e32835cfef1","type":"journal-article","created":{"date-parts":[[2012,12,22]],"date-time":"2012-12-22T03:56:51Z","timestamp":1356148611000},"page":"426-428","source":"Crossref","is-referenced-by-count":5,"title":["Cervical extravasation of bevacizumab"],"prefix":"10.1097","volume":"24","author":[{"given":"Johann","family":"Dr\u00e9anic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romain","family":"Coriat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Mir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00e9raldine","family":"Perkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascaline","family":"Boudou-Rouquette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Brezault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion","family":"Dhooge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Goldwasser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanislas","family":"Chaussade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-12-20210227","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics.","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"R4-12-20210227","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.dld.2010.10.013","article-title":"Safety of 10 min infusion of bevacizumab in combination with 5FU-based chemotherapy in non-selected metastatic colorectal cancer patients.","volume":"43","author":"Coriat","year":"2011","journal-title":"Dig Liver Dis"},{"key":"R6-12-20210227","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/CAD.0b013e32834be51a","article-title":"Recovery of symptomatic extravasation of liposomal doxorubicin after dexrazoxane treatment.","volume":"23","author":"Vos","year":"2012","journal-title":"Anticancer Drugs"},{"key":"R7-12-20210227","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2165\/00002018-199512040-00004","article-title":"Prevention and management of extravasation of cytotoxic drugs.","volume":"12","author":"Bertelli","year":"1995","journal-title":"Drug Saf"},{"key":"R8-12-20210227","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1200\/JCO.1987.5.7.1116","article-title":"Etiology and treatment of chemotherapeutic agent extravasation injuries: a review.","volume":"5","author":"Rudolph","year":"1987","journal-title":"J Clin Oncol"},{"key":"R9-12-20210227","first-page":"5","article-title":"Cetuximab extravasation.","volume":"2010","author":"Thekerar","year":"2010","journal-title":"J Oncol Pharm Pract"},{"key":"R10-12-20210227","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1001\/jama.2011.51","article-title":"Treatment-related mortality with bevacizumab in cancer patients: a meta-analysis.","volume":"305","author":"Ranpura","year":"2011","journal-title":"JAMA"},{"key":"R11-12-20210227","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1093\/annonc\/mdh214","article-title":"Extravasation of systemic hemato-oncological therapies.","volume":"15","author":"Ener","year":"2004","journal-title":"Ann Oncol"}],"container-title":["Anti-Cancer Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CAD.0b013e32835cfef1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T23:17:58Z","timestamp":1620947878000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001813-201304000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":8,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/cad.0b013e32835cfef1","relation":{},"ISSN":["0959-4973"],"issn-type":[{"value":"0959-4973","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}